Search

everythinglearnresearchcommunity

for

Search:↓

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

The Androgen Receptor could be a target for treating diseases like cancer, but more research is needed to confirm the effectiveness of potential treatments.

No definitive link between finasteride and male breast cancer, but further research is needed.

Hair loss in women can be slowed with treatment, but more research needed for better solutions.

Dutasteride caused more penile tissue changes than finasteride, possibly increasing erectile dysfunction risk.

New treatments for prostate cancer and BPH show promise, including novel compounds that target hormone synthesis and response.

Genetic factors affect hair loss, and molecular testing may help predict, diagnose, and treat it.

New ABCA12 gene mutations were linked to a skin condition with scaling and hair loss, and a treatment helped with hair loss in a related case.

Taking oral testosterone with or without dutasteride increases testosterone levels and could be an effective treatment for low testosterone.

We need better ways to test and understand SARMs to make safer and more effective treatments.

Male pattern baldness is an unintended side effect of the body's use of androgens for muscle growth, especially in those genetically prone to it.

Androgens can cause hair growth in some areas but hair loss on the scalp.

DHEA acts like a male hormone on rat skin glands and doesn't turn into female hormones there.

LY320236 is a strong blocker of two enzymes that change testosterone into dihydrotestosterone and might help treat conditions related to male hormones.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

5α-reductase inhibitors like finasteride may not be effective or safe for transgender individuals, and more research is needed.

Finasteride exposure affects gene expression and anogenital distance in male rat fetuses.

Finasteride doesn't affect oral testosterone undecanoate, and high DHT levels may cause acne, prostate issues, and hair loss.

A woman's masculine symptoms were caused by an ovarian tumor, which improved after surgery.

Hair growth is influenced by hormones and goes through different phases; androgens can both promote and inhibit hair growth depending on the body area.

Finasteride changes antioxidant enzyme expression, possibly affecting sperm protection in rats.

A combination of nanomilled oral testosterone and dutasteride normalized testosterone levels in men with low testosterone and is safe for short-term use.

Dogs with sex hormone imbalances may not drink or pee a lot but often lose hair on their body and can have reproductive system issues.

Storing hair follicles in special buffers with added protective substances can increase hair growth and reduce cell death.

Finasteride reduces hair growth in women with hirsutism and works better with electrolysis.

The study concluded that both estrogen and androgen receptors, which decrease with age, are linked to skin aging and may be hormonally regulated.

Certain genetic variants in the androgen receptor are linked to higher PSA levels, potentially affecting prostate cancer screening outcomes.

Blocking interferon-gamma might help treat various autoimmune diseases.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.